메뉴 건너뛰기




Volumn 4, Issue 10, 2009, Pages 1005-1015

Review of knowledge for rational design and identification of anti-tubercular compounds

Author keywords

Antitubercular compounds; Mycobacterium tuberculosis; Rational drug design; Virtual screening

Indexed keywords

1,5 (4 CHLOROPHENYL) 2 METHYL 3 (4 METHYLPIPERAZIN 1 YL)METHYL 1H PYRROLE; 1,5 BIS(4 CHLOROPHENYL) 2 METHYL 3 (4 METHYL 1 PIPERAZINYLMETHYL)PYRROLE; AMINOSALICYLIC ACID; BENZOTHIADIAZINE DERIVATIVE; CLOFAZIMINE DERIVATIVE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LL 3858; NITROFURANYL AMIDE DERIVATIVE; NITROIMIDAOXAZOLE DERIVATIVE; NITROIMIDAZOPYRAN DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PURINE DERIVATIVE; PYRAZINAMIDE; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THYMIDINE MONOPHOSPHATE KINASE INHIBITOR; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

EID: 70349378677     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440903253876     Document Type: Review
Times cited : (10)

References (69)
  • 1
    • 17644388063 scopus 로고    scopus 로고
    • Annulling a dangerous liaison: Vaccination strategies aginst AIDS and tuberculosis
    • Kaufmann SH, McMichael AJ. Annulling a dangerous liaison: vaccination strategies aginst AIDS and tuberculosis. Nat Med 2005;11:S33-44
    • (2005) Nat Med , vol.11
    • Kaufmann, S.H.1    McMichael, A.J.2
  • 2
    • 70349400543 scopus 로고    scopus 로고
    • WHO. World Health Organization.
    • WHO. World Health Organization. Factsheet on tuberculosis; 2009
    • (2009) Factsheet on Tuberculosis
  • 3
    • 70349391169 scopus 로고    scopus 로고
    • Available from
    • Global Alliance for TB Drug Development. Available from: www.tballiance.org
  • 4
    • 33645119729 scopus 로고    scopus 로고
    • Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004
    • Centres for Disease Control and Prevention (CDC)
    • Centres for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. MMWR 2006;55:301-305
    • (2006) MMWR , vol.55 , pp. 301-305
  • 5
    • 13844319812 scopus 로고    scopus 로고
    • The magic bullets and tuberculosis drug targets
    • DOI 10.1146/annurev.pharmtox.45.120403.100120
    • Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005;45:529-564 (Pubitemid 40261816)
    • (2005) Annual Review of Pharmacology and Toxicology , vol.45 , pp. 529-564
    • Zhang, Y.1
  • 6
    • 0019222177 scopus 로고
    • Treatment of tuberculosis. the Mitchell lecture 1979
    • 98-99
    • Mitchison DA. Treatment of tuberculosis. The Mitchell lecture 1979. J R Coll Physicians Lond 1980;14:91-5, 98-99
    • (1980) J R Coll Physicians Lond , vol.14 , pp. 91-95
    • Mitchison, D.A.1
  • 7
    • 0000164959 scopus 로고
    • Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy
    • McCune RM Jr, Tompsett R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 1956;104:737-762
    • (1956) J Exp Med , vol.104 , pp. 737-762
    • McCune Jr., R.M.1    Tompsett, R.2
  • 8
    • 0035038977 scopus 로고    scopus 로고
    • The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps
    • O'Brien RJ, Nunn PP. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am J Respir Crit Care Med 2001;163:1055-1058
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 1055-1058
    • O'Brien, R.J.1    Nunn, P.P.2
  • 9
    • 84960961533 scopus 로고
    • The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial numeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug
    • McCune RM Jr, McDermott W, Tompsett R. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial numeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med 1956;104:763-802
    • (1956) J Exp Med , vol.104 , pp. 763-802
    • McCune Jr., R.M.1    McDermott, W.2    Tompsett, R.3
  • 10
    • 0021798210 scopus 로고
    • Genetically determined variability in acetylation and oxidation. Therapeutic implications
    • Clark DW. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 1985;29:342-375
    • (1985) Drugs , vol.29 , pp. 342-375
    • Clark, D.W.1
  • 11
    • 0018587843 scopus 로고
    • Basic mechanisms of chemotherapy
    • Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979;76:771-81
    • (1979) Chest , vol.76 , pp. 771-781
    • Mitchison, D.A.1
  • 12
    • 0022057647 scopus 로고
    • Antibiotic tolerance among clinical isolates of bacteria
    • Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 1985;7:368-386
    • (1985) Rev Infect Dis , vol.7 , pp. 368-386
    • Handwerger, S.1    Tomasz, A.2
  • 14
    • 0029819235 scopus 로고    scopus 로고
    • Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- And stationary-phase cultures of Mycobacterium tuberculosis
    • Herbert D, Paramasivan CN, Venkatesan P, et al. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1996;40:2296-2299 (Pubitemid 26328035)
    • (1996) Antimicrobial Agents and Chemotherapy , vol.40 , Issue.10 , pp. 2296-2299
    • Herbert, D.1    Paramasivan, C.N.2    Venkatesan, P.3    Kubendiran, G.4    Prabhakar, R.5    Mitchison, D.A.6
  • 18
    • 0028932897 scopus 로고
    • Determination of pharmacophoric geometry for collagenase inhibitors using a novel computational method and its verification using molecular dynamics, NMR, and X-ray crystallography
    • Ghose AK, Logan ME, Treasurywala AM, et al. Determination of pharmacophoric geometry for collagenase inhibitors using a novel computational method and its verification using molecular dynamics, NMR, and X-ray crystallography. J Am Chem Soc 1995;117:4671-4682
    • (1995) J Am Chem Soc , vol.117 , pp. 4671-4682
    • Ghose, A.K.1    Logan, M.E.2    Treasurywala, A.M.3
  • 20
    • 0037472770 scopus 로고    scopus 로고
    • Topomer CoMFA: A design methodology for rapid lead optimization
    • Cramer RD. Topomer CoMFA: a design methodology for rapid lead optimization. J Med Chem 2003;46:374-388
    • (2003) J Med Chem , vol.46 , pp. 374-388
    • Cramer, R.D.1
  • 23
    • 0036835460 scopus 로고    scopus 로고
    • Integration of virtual and high-throughput screening
    • Bajorath J. Integration of virtual and high-throughput screening. Nat Rev Drug Discov 2002;1:882-894
    • (2002) Nat Rev Drug Discov , vol.1 , pp. 882-894
    • Bajorath, J.1
  • 24
    • 8844263008 scopus 로고    scopus 로고
    • Docking and scoring in virtual screening for drug discovery: Methods and applications
    • DOI 10.1038/nrd1549
    • Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004;3:935-949 (Pubitemid 39529931)
    • (2004) Nature Reviews Drug Discovery , vol.3 , Issue.11 , pp. 935-949
    • Kitchen, D.B.1    Decornez, H.2    Furr, J.R.3    Bajorath, J.4
  • 25
    • 33749245117 scopus 로고    scopus 로고
    • Prediction of protein-ligand interactions. Docking and scoring: Successes and gaps
    • Leach AR, Shoichet BK, Peishoff CE. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. J Med Chem 2006;49:5851-5855
    • (2006) J Med Chem , vol.49 , pp. 5851-5855
    • Leach, A.R.1    Shoichet, B.K.2    Peishoff, C.E.3
  • 26
    • 23844449940 scopus 로고    scopus 로고
    • Computer-based de novo design of drug-like molecules
    • DOI 10.1038/nrd1799
    • Schneider G, Fechner U. Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 2005;4:649-663 (Pubitemid 41149759)
    • (2005) Nature Reviews Drug Discovery , vol.4 , Issue.8 , pp. 649-663
    • Schneider, G.1    Fechner, U.2
  • 30
    • 0036740917 scopus 로고    scopus 로고
    • Why do we need so many chemical similarity methods?
    • Sheridan RP, Kearsley SK. Why do we need so many chemical similarity methods? Drug Discov Today 2002;7:903-911
    • (2002) Drug Discov Today , vol.7 , pp. 903-911
    • Sheridan, R.P.1    Kearsley, S.K.2
  • 31
    • 10344230435 scopus 로고    scopus 로고
    • Molecular similarity: A key technique in molecular informatics
    • Bender A, Glen RC. Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2004;2:3204-3218
    • (2004) Org Biomol Chem , vol.2 , pp. 3204-3218
    • Bender, A.1    Glen, R.C.2
  • 34
    • 0026642983 scopus 로고
    • 3D database searching in drug design
    • Martin YC. 3D database searching in drug design. J Med Chem 1992;35:2145-2154
    • (1992) J Med Chem , vol.35 , pp. 2145-2154
    • Martin, Y.C.1
  • 36
    • 0030574268 scopus 로고    scopus 로고
    • Structure based drug design
    • Blundell TL. Structure based drug design. Nature 1996;384:23-26
    • (1996) Nature , vol.384 , pp. 23-26
    • Blundell, T.L.1
  • 37
    • 0033757822 scopus 로고    scopus 로고
    • An overview of structural genomics
    • Burley SK. An overview of structural genomics. Nat Struct Biol 2000;7:932-934
    • (2000) Nat Struct Biol , vol.7 , pp. 932-934
    • Burley, S.K.1
  • 40
    • 0027411717 scopus 로고
    • In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis
    • Ashtekar DR, Costa-Perira R, Nagrajan K, et al. In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis. Antimicrob Agents Chemother 1993;37:183-186
    • (1993) Antimicrob Agents Chemother , vol.37 , pp. 183-186
    • Ashtekar, D.R.1    Costa-Perira, R.2    Nagrajan, K.3
  • 41
    • 15144354135 scopus 로고    scopus 로고
    • Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring
    • Tucker JA, Allwine DA, Grega KC, et al. Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. J Med Chem 1998;41:3727-3735
    • (1998) J Med Chem , vol.41 , pp. 3727-3735
    • Tucker, J.A.1    Allwine, D.A.2    Grega, K.C.3
  • 43
    • 0023748768 scopus 로고
    • Mechanism of action of DuP 721: Inhibition of an early event during initiation of protein synthesis
    • Eustice DC, Feldman PA, Zajac I, Slee AM. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob Agents Chemother 1988;32:1218-1222
    • (1988) Antimicrob Agents Chemother , vol.32 , pp. 1218-1222
    • Eustice, D.C.1    Feldman, P.A.2    Zajac, I.3    Slee, A.M.4
  • 44
    • 0142105859 scopus 로고    scopus 로고
    • Treatment of Mycobacterium avium-intracellulare complex lung disease with a Macrolide, Ethambutol, and Clofazimine
    • Field SK, Cowie RL. Treatment of Mycobacterium avium-intracellulare complex lung disease with a Macrolide, Ethambutol, and Clofazimine. Chest 2003;124:1482-1486
    • (2003) Chest , vol.124 , pp. 1482-1486
    • Field, S.K.1    Cowie, R.L.2
  • 45
    • 15044339425 scopus 로고    scopus 로고
    • Antitubercular agents. Part 1: Synthesis of phthalimido- and naphthalimidolinked phenazines as new prototypeantitubercular agents
    • Kamal A, Babu AH, Ramana AV, et al. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimidolinked phenazines as new prototypeantitubercular agents. Bioorg Med Chem Lett 2005;15:1923-1926
    • (2005) Bioorg Med Chem Lett , vol.15 , pp. 1923-1926
    • Kamal, A.1    Babu, A.H.2    Ramana, A.V.3
  • 46
    • 29744457268 scopus 로고    scopus 로고
    • Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents
    • DOI 10.1021/jm050765n
    • Tangalapally RP, Yendapally R, Lee RE, et al. Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents. J Med Chem 2005;48:8261-8269 (Pubitemid 43032535)
    • (2005) Journal of Medicinal Chemistry , vol.48 , Issue.26 , pp. 8261-8269
    • Tangallapally, R.P.1    Yendapally, R.2    Lee, R.E.3    Lenaerts, A.J.M.4    Lee, R.E.5
  • 48
    • 0037075792 scopus 로고    scopus 로고
    • Synthesis and antimycobacterial activity of 6-arylpurines: The requirements for the N-9 substituent in active antimycobacterial purines
    • DOI 10.1021/jm0110284
    • Gundersen LL, Meyer JN, Spilsberg B. Synthesis and antimycobacterial activity of 6- arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines. J Med Chem 2002;45:1383-1386 (Pubitemid 34263575)
    • (2002) Journal of Medicinal Chemistry , vol.45 , Issue.6 , pp. 1383-1386
    • Gundersen, L.-L.1    Nissen-Meyer, J.2    Spilsberg, B.3
  • 49
    • 0035833112 scopus 로고    scopus 로고
    • Antimycobacterial activity of 9-sulfonylated/sulfenylated-6- mercaptopurine derivatives
    • DOI 10.1016/S0960-894X(01)00266-9, PII S0960894X01002669
    • Scozzafava A, Mastrolorenzo A, Supuran CT. Antimycobacterial activity of 9-sulfonylated sulfenylated-6-mercaptopurine derivatives. Bioorg Med Chem Lett 2001;11:1675-1678 (Pubitemid 32568295)
    • (2001) Bioorganic and Medicinal Chemistry Letters , vol.11 , Issue.13 , pp. 1675-1678
    • Scozzafava, A.1    Mastrolorenzo, A.2    Supuran, C.T.3
  • 50
    • 15044346662 scopus 로고    scopus 로고
    • Novel fluoroquinolones: Design, synthesis, and in vivo activity in mice against mycobacterium tuberculosis H37Rv
    • Shindikar AV, Viswanathan CL. Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against mycobacterium tuberculosis H37Rv. Bioorg Med Chem Lett 2005;15:1803-1806
    • (2005) Bioorg Med Chem Lett , vol.15 , pp. 1803-1806
    • Shindikar, A.V.1    Viswanathan, C.L.2
  • 52
    • 28844503532 scopus 로고    scopus 로고
    • Anti-tubercular agents. Part 3: Benzothiadiazines as a novel scaffold for anti-mycobacterim activiy
    • Kamal A, Reddy KS, Ahmed SK, et al. Anti-tubercular agents. Part 3: benzothiadiazines as a novel scaffold for anti-mycobacterim activiy. Bioorg Med Chem 2006;14:650-658
    • (2006) Bioorg Med Chem , vol.14 , pp. 650-658
    • Kamal, A.1    Reddy, K.S.2    Ahmed, S.K.3
  • 53
    • 34548573520 scopus 로고    scopus 로고
    • Antitubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines
    • Kamal A, Ahmed SK, Reddy KS, et al. Antitubercular agents. Part IV: synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines. Bioorg Med Chem Lett 2007;17:5419-5422
    • (2007) Bioorg Med Chem Lett , vol.17 , pp. 5419-5422
    • Kamal, A.1    Ahmed, S.K.2    Reddy, K.S.3
  • 56
    • 57649146532 scopus 로고    scopus 로고
    • A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis
    • Shen H, Wang F, Zhang Y, et al. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis. FEBS J 2009;276:144-154
    • (2009) FEBS J , vol.276 , pp. 144-154
    • Shen, H.1    Wang, F.2    Zhang, Y.3
  • 57
    • 44249107292 scopus 로고    scopus 로고
    • Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening
    • DOI 10.1016/j.bmcl.2008.05.003, PII S0960894X08004861
    • Segura-Cabrera A, Rodríguez-Pérez MA. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening. Bioorg Med Chem Lett 2008;18:3152-3157 (Pubitemid 351721011)
    • (2008) Bioorganic and Medicinal Chemistry Letters , vol.18 , Issue.11 , pp. 3152-3157
    • Segura-Cabrera, A.1    Rodriguez-Perez, M.A.2
  • 58
    • 53549091061 scopus 로고    scopus 로고
    • Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening
    • Cho Y, Ioerger TR, Sacchettini JC. Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening. J Med Chem 2008;51:5984-5992
    • (2008) J Med Chem , vol.51 , pp. 5984-5992
    • Cho, Y.1    Ioerger, T.R.2    Sacchettini, J.C.3
  • 59
    • 10344230435 scopus 로고    scopus 로고
    • Molecular similarity: A key technique in molecular informatics
    • Bender A, Glen RC. Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2004;2:3204-3218
    • (2004) Org Biomol Chem , vol.2 , pp. 3204-3218
    • Bender, A.1    Glen, R.C.2
  • 60
    • 33749005650 scopus 로고    scopus 로고
    • Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of Mycobacterium tuberculosis
    • DOI 10.1002/cmdc.200600026
    • Manetti F, Magnani M, Castagnolo D, et al. Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of Mycobacterium tuberculosis. ChemMedChem 2006;1:973-989 (Pubitemid 44448797)
    • (2006) ChemMedChem , vol.1 , Issue.9 , pp. 973-989
    • Manetti, F.1    Magnani, M.2    Castagnolo, D.3    Passalacqua, L.4    Botta, M.5    Corelli, F.6    Saddi, M.7    Deidda, D.8    De Logu, A.9
  • 62
    • 0031024171 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • DOI 10.1016/S0169-409X(96)00423-1, PII S0169409X96004231
    • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25 (Pubitemid 27046991)
    • (1997) Advanced Drug Delivery Reviews , vol.23 , Issue.1-3 , pp. 3-25
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 64
    • 34247842959 scopus 로고    scopus 로고
    • Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv
    • DOI 10.1016/j.bmcl.2007.03.053, PII S0960894X07003447
    • Agrawal H, Kumar A, Bal NC, et al. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv. Bioorg Med Chem Lett 2007;17:3053-3058 (Pubitemid 46702633)
    • (2007) Bioorganic and Medicinal Chemistry Letters , vol.17 , Issue.11 , pp. 3053-3058
    • Agrawal, H.1    Kumar, A.2    Bal, N.C.3    Siddiqi, M.I.4    Arora, A.5
  • 65
    • 0036773752 scopus 로고    scopus 로고
    • The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis
    • Parish T, Stoker NG. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 2002;148:3069-3077 (Pubitemid 35243706)
    • (2002) Microbiology , vol.148 , Issue.10 , pp. 3069-3077
    • Parish, T.1    Stoker, N.G.2
  • 66
    • 4444225021 scopus 로고    scopus 로고
    • Design, synthesis, and evaluation of aza inhibitors of chorismate mutase
    • DOI 10.1016/j.bmc.2004.06.037, PII S0968089604004821
    • Hediger ME. Design, synthesis, and evaluation of aza inhibitors of chorismate mutase. Bioorg Med Chem 2004;15:4995-5010 (Pubitemid 39164408)
    • (2004) Bioorganic and Medicinal Chemistry , vol.12 , Issue.18 , pp. 4995-5010
    • Hediger, M.E.1
  • 67
    • 61949212798 scopus 로고    scopus 로고
    • Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints
    • Kumar A, Chaturvedi V, Bhatnagar S, et al. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints. J Chem Inf Model 2009;49:35-42
    • (2009) J Chem Inf Model , vol.49 , pp. 35-42
    • Kumar, A.1    Chaturvedi, V.2    Bhatnagar, S.3
  • 68
    • 0346962971 scopus 로고    scopus 로고
    • Structural Interaction Fingerprint (SIFt): A novel method for analysing three-dimensional protein- ligand binding interactions
    • Deng Z, Chuaqui C, Singh J. Structural Interaction Fingerprint (SIFt): a novel method for analysing three-dimensional protein- ligand binding interactions. J Med Chem 2004;47:337-344
    • (2004) J Med Chem , vol.47 , pp. 337-344
    • Deng, Z.1    Chuaqui, C.2    Singh, J.3
  • 69
    • 12144249613 scopus 로고    scopus 로고
    • Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening
    • DOI 10.1021/jm049312t
    • Chuaqui C, Deng Z, Singh J. Interaction profiles of protein kinase inhibitor complexes and their application to virtual screening. J Med Chem 2005;48:121-133 (Pubitemid 40105253)
    • (2005) Journal of Medicinal Chemistry , vol.48 , Issue.1 , pp. 121-133
    • Chuaqui, C.1    Deng, Z.2    Singh, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.